S'abonner

Bone morphogenetic protein-2 as a novel biomarker for refractory chronic rhinosinusitis with nasal polyps - 04/08/21

Doi : 10.1016/j.jaci.2021.02.027 
Jin Youp Kim, MD a, b, , Suha Lim, BSc c, d, e, , Hee-Suk Lim, MA a, Yi-Sook Kim, BSc c, d, Kyoung Mi Eun, BSc a, Roza Khalmuratova, MD, PhD c, Yuju Seo, MD a, Joon Kon Kim, MD a, Young Seok Kim, MD a, Min-Kyung Kim, MD a, Siyeon Jin, MD a, Seung Cheol Han, MD a, Suyeon Pyo, MD a, Seung-No Hong, MD a, Jong-Wan Park, MD, PhD c, d, e, g, Hyun-Woo Shin, MD, PhD c, d, e, f, g, , , Dae Woo Kim, MD, PhD a, ,
a Department of Otorhinolaryngology-Head & Neck Surgery, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea 
b Interdisciplinary Program of Medical Informatics, Seoul National University College of Medicine, Seoul, Korea 
c Obstructive Upper Airway Research Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea 
d Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea 
e Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea 
f Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Korea 
g Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea 

Corresponding author: Dae Woo Kim, MD, PhD, Department of Otorhinolaryngology-Head and Neck Surgery, Boramae Medical Center, 425 Shindaebang 2-dong, Dongjak-gu, Seoul 07061, South Korea.Department of Otorhinolaryngology-Head and Neck SurgeryBoramae Medical Center425 Shindaebang 2-dongDongjak-guSeoulSouth Korea07061∗∗Hyun-Woo Shin, MD, PhD, Department of Pharmacology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, South Korea.Department of PharmacologySeoul National University College of Medicine103 Daehak-roJongno-guSeoulSouth Korea03080

Abstract

Background

Bone morphogenetic proteins (BMPs), which are members of the TGF-β superfamily, regulate bone remodeling by stimulating osteoblasts and osteoclasts. Although the association between osteitis and poor surgical outcomes is well known in patients with chronic rhinosinusitis (CRS), BMPs have not been fully investigated as potential biomarkers for the prognosis of CRS.

Objective

Our aim was to investigate the role of BMPs in osteitis in patients with CRS with nasal polyps (NPs) (CRSwNPs), as well as associations between BMPs and inflammatory markers in sinonasal tissues from patients with CRSwNP.

Methods

We investigated the expression of 6 BMPs (BMP-2, BMP-4, BMP-6, BMP-7, BMP-9, and BMP-10) and their cellular origins in NPs of human subjects by using immunohistochemistry and ELISA of NP tissues. Exploratory factor analysis was performed to identify associations between BMPs and inflammatory markers. Air-liquid interface cell culture of human nasal epithelial cells was performed to evaluate the induction of the epithelial-mesenchymal transition by BMPs.

Results

Of the 6 BMPs studied, BMP-2 and BMP-7 were associated with refractoriness. Only BMP-2 concentrations were higher in patients with severe osteitis and advanced disease extent according to the computed tomography findings. Eosinophils and some macrophages were identified as cellular sources of BMP-2 in immunofluorescence analysis. An in vitro experiment revealed that BMP-2 induced epithelial-mesenchymal transition in air-liquid interface–cultured human nasal epithelial cells, particularly in a TH2 milieu.

Conclusion

BMP-2 could reflect the pathophysiology of mucosa and bone remodeling and may be a novel biomarker for refractory CRSwNP.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : Nasal polyp, bone morphogenetic proteins, sinusitis, osteitis, biomarker

Abbreviations used : ALI, AUC, BMP, BMPR1A, CRS, CRSwNP, CT, EFA, EMBP, EMT, GOSS, HNE, hNEC, LM CT, NP, r, ROC, RUNX2, TEER, UP


Plan


 Supported by the National Research Foundation of Korea (grant NRF-2019R1A2C2087170 [to D.W.K.] and grant 2020R1A4A2002903 [to H.W.S.]), the Seoul Metropolitan Government Seoul National University Boramae Medical Center (focused clinical research grant-in-aid 03-2019-1 [to D.W.K.]), and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant HI17C1669 to [H.W.S.]).
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2021  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 148 - N° 2

P. 461 - août 2021 Retour au numéro
Article précédent Article précédent
  • Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps
  • Di Wu, Bing Yan, Yang Wang, Chengshuo Wang, Luo Zhang
| Article suivant Article suivant
  • High-fat diet induces a predisposition to follicular hyperkeratosis and neutrophilic folliculitis in mice
  • Satoshi Nakamizo, Tetsuya Honda, Tomohito Sato, Md. Al Mamun, Zachary Chow, Kaibo Duan, Josephine Lum, Kahbing Jasmine Tan, Kaori Tomari, Reiko Sato, Akihiko Kitoh, Angeline S.L. Tay, John E.A. Common, Ng Lai Guan, Mitsutoshi Setou, Florent Ginhoux, Kenji Kabashima

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.